GlassScriptPhysician profile
Geoffrey L Tyson
NPI 1679610778
$17,170.80
in general payments reported to CMS, 2019-2025
29 companies · $3,592 in 2025
The $3,592 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,285 · 2020: $861 · 2021: $550 · 2022: $546 · 2023: $2,357 · 2024: $5,981 · 2025: $3,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,527 · Food and Beverage: $5,306 · Education: $96.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,527.49 |
| Food and Beverage | $5,305.56 |
| Education | $96.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,746.03 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Spectra Wavewriter |
| Abbott Laboratories | $2,166.36 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $2,070.55 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Vertiflex, INC. | $2,052.49 | 2019 | |
| Nalu Medical, INC. | $1,246.05 | 2021-2024 | Nalu Neurostimulation System |
| Si-Bone, INC. | $1,182.38 | 2024-2025 | |
| Mml US, INC. | $640.38 | 2024 | Reactiv8 |
| Pfizer INC. | $553.83 | 2020-2021 | |
| Painteq LLC | $406.62 | 2023-2024 | Painteq |
| Nevro Corp. | $391.66 | 2024 | Senza |
| Curonix LLC | $331.24 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Assertio Therapeutics, INC. | $256.95 | 2019-2020 | |
| Vertos Medical, INC. | $221.76 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $215.70 | 2023 | Sprint Pns System |
| Biotronik Nro, INC. | $156.71 | 2024-2025 | Prospera |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $94.03 | 2019-2020 | |
| Saluda Medical Americas, INC. | $87.80 | 2023-2025 | Evoke, Evoke Scs |
| Stimwave Technologies Incorporated | $83.96 | 2019-2020 | |
| Relievant Medsystems, INC. | $38.97 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $34.68 | 2020-2023 | Belbuca |
| Supernus Pharmaceuticals, INC. | $31.45 | 2019 | |
| Mdd US Operations, LLC | $31.05 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $30.85 | 2025 | |
| Lundbeck LLC | $22.03 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $18.40 | 2019 | |
| Sentynl Therapeutics, INC. | $17.36 | 2019 | |
| Kaleo, INC. | $17.18 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.25 | 2019 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.